Torthaí cuardaigh - Pankit Vachhani

Beachtaigh na torthaí
  1. 1
    Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: Case Series and Review of the Literature

    Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: Case Series and Review of the Literature de réir Nikhil Agrawal, Arjun Khunger, Pankit Vachhani, Teresa A. Colvin, Alexander Hattoum, Edward Spangenthal, Anne B. Curtis, Grace K. Dy, Marc S. Ernstoff, Igor Puzanov

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Interferons in the treatment of myeloproliferative neoplasms

    Interferons in the treatment of myeloproliferative neoplasms de réir Pankit Vachhani, John O. Mascarenhas, Prithviraj Bose, Gabriela S. Hobbs, Abdulraheem Yacoub, Jeanne Palmer, Aaron T. Gerds, Lucia Masárová, Andrew Kuykendall, Raajit K. Rampal, Ruben A. Mesa, Srđan Verstovšek

    Foilsithe / Cruthaithe 2024
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Venetoclax and Hypomethylating Agents as First-line Treatment in Newly Diagnosed Patients with AML in a Predominately Community Setting in the US

    Venetoclax and Hypomethylating Agents as First-line Treatment in Newly Diagnosed Patients with AML in a Predominately Community Setting in the US de réir Pankit Vachhani, Evelyn M. Flahavan, Tao Xu, Esprit Ma, Melissa Montez, Anda Gershon, Maika Onishi, Huan Jin, Grace Ku, Brannon Flores, Cat N. Bui, Jonathan Abbas, William B. Donnellan

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    PB2198: TRIAL IN PROGRESS: AN OPEN-LABEL, GLOBAL, MULTICENTER, PHASE 1B/2 STUDY OF TL-895, A BRUTON’S TYROSINE KINASE INHIBITOR (BTKI), ADDED TO RUXOLITINIB (RUX) IN PATIENTS (PTS) WITH MYELOFIBROSIS (MF)

    PB2198: TRIAL IN PROGRESS: AN OPEN-LABEL, GLOBAL, MULTICENTER, PHASE 1B/2 STUDY OF TL-895, A BRUTON’S TYROSINE KINASE INHIBITOR (BTKI), ADDED TO RUXOLITINIB (RUX) IN PATIENTS (PTS)... de réir Francesca Palandri, Stefanie Gröpper, Michaël Loschi, Marcelo Bellesso, Sebastian Grosicki, Pilar Giraldo, Claire Harrison, Tracy Clevenger, Nikki Stuart, Hope Qamoos, Gregory Vosganian, Wayne P. Rothbaum, Srđan Verstovšek, Pankit Vachhani

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Preliminary Results from a Phase 1 First-in-Human Study of AMG 673, a Novel Half-Life Extended (HLE) Anti-CD33/CD3 BiTE® (Bispecific T-Cell Engager) in Patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

    Preliminary Results from a Phase 1 First-in-Human Study of AMG 673, a Novel Half-Life Extended (HLE) Anti-CD33/CD3 BiTE® (Bispecific T-Cell Engager) in Patients with Relapsed/Refra... de réir Marion Subklewe, Anthony S. Stein, Roland B. Walter, Ravi Bhatia, Andrew H. Wei, David Ritchie, Veit Bücklein, Pankit Vachhani, Tian Dai, Antreas Hindoyan, Suresh Agarwal, Abraham Anderson, Sophia K. Khaldoyanidi, Farhad Ravandi

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Quality‐Adjusted Time Without Symptoms of Disease or Toxicity (Q‐<scp>TWiST</scp>) in Patients With Newly Diagnosed Philadelphia Chromosome‐Positive Acute Lymphoblastic Leukemia: A Comparison of Ponatinib Versus Imatinib

    Quality‐Adjusted Time Without Symptoms of Disease or Toxicity (Q‐<scp>TWiST</scp>) in Patients With Newly Diagnosed Philadelphia Chromosome‐Positive Acute Lymphoblastic Leukemia: A... de réir Ajibade Ashaye, Ling Shi, Ibrahim Aldoss, Pau Montesinos, Pankit Vachhani, Vanderson Rocha, Cristina Papayannidis, Jessica T. Leonard, Maria R. Baer, Josep‐María Ribera, James McCloskey, Jianxiang Wang, Deepali Rane, Shien Guo

    Foilsithe / Cruthaithe 2025
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Patient-reported outcomes in Philadelphia chromosome-positive acute lymphoblastic leukemia patients treated with ponatinib or imatinib: results from the PhALLCON trial

    Patient-reported outcomes in Philadelphia chromosome-positive acute lymphoblastic leukemia patients treated with ponatinib or imatinib: results from the PhALLCON trial de réir Ajibade Ashaye, Ling Shi, Ibrahim Aldoss, Pau Montesinos, Pankit Vachhani, Vanderson Rocha, Cristina Papayannidis, Jessica T. Leonard, Maria R. Baer, Josep‐María Ribera, James A. McCloskey, Jianxiang Wang, Sujun Gao, Deepali Rane, Shien Guo

    Foilsithe / Cruthaithe 2025
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Ponatinib Versus Imatinib in Patients with Newly Diagnosed Ph+ ALL: Subgroup Analysis of the Phase 3 Phallcon Study

    Ponatinib Versus Imatinib in Patients with Newly Diagnosed Ph+ ALL: Subgroup Analysis of the Phase 3 Phallcon Study de réir Ibrahim Aldoss, Josep‐María Ribera, Hagop M. Kantarjian, Pau Montesinos, Jessica T. Leonard, David Gómez‐Almaguer, Maria R. Baer, Carlo Gambacorti‐Passerini, James McCloskey, Yosuke Minami, Cristina Papayannidis, Vanderson Rocha, Philippe Rousselot, Pankit Vachhani, Eunice S. Wang, Meliessa Hennessy, Niti Patel, Alexander Vorog, Bingxia Wang, Elias Jabbour

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Addition of Navitoclax to Ongoing Ruxolitinib Therapy for Patients With Myelofibrosis With Progression or Suboptimal Response: Phase II Safety and Efficacy

    Addition of Navitoclax to Ongoing Ruxolitinib Therapy for Patients With Myelofibrosis With Progression or Suboptimal Response: Phase II Safety and Efficacy de réir Claire Harrison, Jacqueline S. Garcia, Tim C. P. Somervaille, James M. Foran, Srđan Verstovšek, Catriona Jamieson, Ruben A. Mesa, Ellen K. Ritchie, Srinivas K. Tantravahi, Pankit Vachhani, Casey L. O’Connell, Rami S. Komrokji, Jason G. Harb, Jessica E. Hutti, Leanne Holes, Abdullah Al Masud, Silpa Nuthalapati, Jalaja Potluri, Naveen Pemmaraju

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Oral Abstract: ALL-300 First Report of PhALLCON: A Phase 3 Study Comparing Ponatinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphocytic Leukemia

    Oral Abstract: ALL-300 First Report of PhALLCON: A Phase 3 Study Comparing Ponatinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphocytic Leukemia de réir Elias Jabbour, Hagop M. Kantarjian, Ibrahim Aldoss, Pau Montesinos, Jessica T. Leonard, David Gómez‐Almaguer, Maria R. Baer, Carlo Gambacorti‐Passerini, James McCloskey, Yosuke Minami, Cristina Papayannidis, Vanderson Rocha, Philippe Rousselot, Pankit Vachhani, Eunice S. Wang, Meliessa Hennessy, Niti Patel, Alexander Vorog, Bingxia Wang, Tammie C. Yeh, Josep‐María Ribera

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    ALL-300 First Report of PhALLCON: A Phase 3 Study Comparing Ponatinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphocytic Leukemia

    ALL-300 First Report of PhALLCON: A Phase 3 Study Comparing Ponatinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphocytic Leukemia de réir Elias Jabbour, Hagop M. Kantarjian, Ibrahim Aldoss, Pau Montesinos, Jessica T. Leonard, David Gómez‐Almaguer, Maria R. Baer, Carlo Gambacorti‐Passerini, James McCloskey, Yosuke Minami, Cristina Papayannidis, Vanderson Rocha, Philippe Rousselot, Pankit Vachhani, Eunice S. Wang, Meliessa Hennessy, Niti Patel, Alexander Vorog, Bingxia Wang, Tammie C. Yeh, Josep‐María Ribera

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis

    Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis de réir Igor Puzanov, Poornima Subramanian, Yan Yatsynovich, David M. Jacobs, Maya R. Chilbert, Umesh C. Sharma, Fumito Ito, Steven Feuerstein, Filip Stefanovic, Benjamin Switzer, Mark D. Hicar, Anne B. Curtis, Edward Spangenthal, Grace K. Dy, Marc S. Ernstoff, Pankit Vachhani, Brian Page, Nikhil Agrawal, Arjun Khunger, Ankita Kapoor, Alexander Hattoum, Jerome J. Schentag

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    S110: PHALLCON: A PHASE 3 STUDY COMPARING PONATINIB VERSUS IMATINIB IN NEWLY DIAGNOSED PH+ ALL

    S110: PHALLCON: A PHASE 3 STUDY COMPARING PONATINIB VERSUS IMATINIB IN NEWLY DIAGNOSED PH+ ALL de réir Elias Jabbour, Hagop M. Kantarjian, Ibrahim Aldoss, Pau Montesinos, Jessica T. Leonard, David Gómez Gómez, Maria R. Baer, Carlo Gambacorti‐Passerini, James McCloskey, Yosuke Minami, Cristina Papayannidis, Vanderson Rocha, Philippe Rousselot, Pankit Vachhani, Eunice S. Wang, Meliessa Hennessy, Niti Patel, Alexander Vorog, Bingxia Wang, Huilan Yao, Tammie C. Yeh, Josep‐María Ribera

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML

    Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML de réir H. Moses Murdock, Haesook T. Kim, Nathan Denlinger, Pankit Vachhani, Bryan C. Hambley, Bryan Manning, Shannon H. Gier, Christina Cho, Harrison Tsai, Shannon R. McCurdy, Vincent T. Ho, John Koreth, Robert J. Soiffer, Jerome Ritz, Martin Carroll, Sumithira Vasu, Miguel‐Angel Perales, Eunice S. Wang, Lukasz P. Gondek, Steven M. Devine, Edwin P. Alyea, R. Coleman Lindsley, Christopher J. Gibson

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study

    Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study de réir Yana G. Najjar, Kristina Navrazhina, Fei Ding, Roma Bhatia, Katy K. Tsai, Kelly Abbate, Barbara Durden, Zeynep Eroglu, Shailender Bhatia, Song Park, Akansha Chowdhary, Sunandana Chandra, Jonathan Kennedy, Igor Puzanov, Marc S. Ernstoff, Pankit Vachhani, Joseph J. Drabick, Arun D. Singh, Xu Tan, Jessica Yang, Richard D. Carvajal, Daniel K. Manson, John M. Kirkwood, Justine V. Cohen, Ryan J. Sullivan, Douglas B. Johnson, Pauline Funchain, Alexander N. Shoushtari

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Myeloproliferative Neoplasms, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

    Myeloproliferative Neoplasms, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology de réir Aaron T. Gerds, Jason Gotlib, Haris Ali, Prithviraj Bose, Andrew Dunbar, Amro Elshoury, Tracy I. George, Krishna Gundabolu, Elizabeth O. Hexner, Gabriela S. Hobbs, Tania Jain, Catriona Jamieson, Paul Kaesberg, Andrew Kuykendall, Yazan F. Madanat, Brandon McMahon, Sanjay Mohan, Kalyan Nadiminti, Stephen T. Oh, Animesh Pardanani, Nikolai A. Podoltsev, Lindsay Rein, Rachel B. Salit, Brady L. Stein, Moshe Talpaz, Pankit Vachhani, Martha Wadleigh, Sarah Wall, Dawn C. Ward, Mary Anne Bergman, Cindy L. Hochstetler

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    Myeloid/Lymphoid Neoplasms with Eosinophilia and TK Fusion Genes, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology

    Myeloid/Lymphoid Neoplasms with Eosinophilia and TK Fusion Genes, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology de réir Aaron T. Gerds, Jason Gotlib, Prithviraj Bose, Michael W. Deininger, Andrew Dunbar, Amro Elshoury, Tracy I. George, Ivana Gojo, Krishna Gundabolu, Elizabeth O. Hexner, Gabriela S. Hobbs, Tania Jain, Catriona Jamieson, Andrew Kuykendall, Brandon McMahon, Sanjay Mohan, Vivian G. Oehler, Stephen T. Oh, Animesh Pardanani, Nikolai A. Podoltsev, Erik A. Ranheim, Lindsay Rein, Rachel B. Salit, David S. Snyder, Brady L. Stein, Moshe Talpaz, Swapna Thota, Pankit Vachhani, Martha Wadleigh, Katherine Walsh, Dawn C. Ward, Mary Anne Bergman, Hema Sundar

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia

    Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia de réir Mohamed L. Sorror, Barry E. Storer, Amir T. Fathi, Andrew M. Brunner, Aaron T. Gerds, Mikkael A. Sekeres, Sudipto Mukherjee, Bruno C. Medeiros, Eunice S. Wang, Pankit Vachhani, Paul J. Shami, Esteban Peña, Mahmoud Elsawy, Kehinde Adekola, Selina M. Luger, Maria R. Baer, David A. Rizzieri, Tanya M. Wildes, Jamie Koprivnikar, Julie Smith, Mitchell Garrison, Kiarash Kojouri, Wendy M. Leisenring, Lynn Onstad, Jennifer E. Nyland, Pamela S. Becker, Jeannine S. McCune, Stephanie J. Lee, Brenda M. Sandmaier, Frederick R. Appelbaum, Elihu H. Estey

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021

    NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021 de réir Daniel A. Pollyea, Dale L. Bixby, Alexander E. Perl, Vijaya Raj Bhatt, Jessica K. Altman, Frederick R. Appelbaum, Marcos de Lima, Amir T. Fathi, James M. Foran, Ivana Gojo, Aric C. Hall, Meagan A. Jacoby, Jeffrey E. Lancet, Gabriel N. Mannis, Guido Marcucci, Michael G. Martin, Alice S. Mims, Jadee Neff, Reza Nejati, Rebecca L. Olin, Mary‐Elizabeth M. Percival, Thomas Prébet, Amanda Przespolewski, Dinesh S. Rao, Farhad Ravandi‐Kashani, Paul J. Shami, Richard M. Stone, Stephen A. Strickland, Kendra Sweet, Pankit Vachhani, Matthew J. Wieduwilt, Kristina M. Gregory, Ndiya Ogba, Martin S. Tallman

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    Acute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology

    Acute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology de réir Daniel A. Pollyea, Jessica K. Altman, Rita Assi, Dale L. Bixby, Amir T. Fathi, James M. Foran, Ivana Gojo, Aric C. Hall, Brian A. Jonas, Ashwin Kishtagari, Jeffrey E. Lancet, Lori J. Maness, James K. Mangan, Gabriel N. Mannis, Guido Marcucci, Alice S. Mims, Kelsey Moriarty, Moaath K. Mustafa Ali, Jadee Neff, Reza Nejati, Rebecca L. Olin, Mary-Elizabeth Percival, Alexander E. Perl, Amanda Przespolewski, Dinesh S. Rao, Farhad Ravandi, Rory M. Shallis, Paul J. Shami, Eytan M. Stein, Richard M. Stone, Kendra Sweet, Swapna Thota, Geoffrey L. Uy, Pankit Vachhani, Carly J. Cassara, Deborah A. Freedman-Cass, Katie Stehman

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: